Dopaminochrome induces caspase-independent apoptosis in the mesencephalic cell line, MN9D

Journal of Neurochemistry

Volumn 122, Issue 1, 2012, Pages 175-184

  Linsenbardt, Andrew J ^a   Breckenridge, Julie M ^a   Wilken, Gerald H ^a   MacArthur, Heather ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIF; apoptosis; dopaminochrome; neurodegeneration; Parkinson's disease; PARP1

Indexed keywords

5 AMINOISOQUINOLINE DERIVATIVE; 5 DIHYDROXYINDOLE TAUTOMER; APOPTOSIS INDUCING FACTOR; CASPASE; CASPASE 3; DOPACHROME TAUTOMERASE; DOPAMINOCHROME; ISOQUINOLINE DERIVATIVE; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROPIDIUM IODIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL LINE; CELL NUCLEUS; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MESENCEPHALON; MITOCHONDRION; NERVE DEGENERATION; NICK END LABELING; PARKINSON DISEASE; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TRANSPORT; SUBSTANTIA NIGRA; WESTERN BLOTTING;

ANIMALS; ANNEXIN A5; APOPTOSIS; CASPASE 3; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; DEOXYGUANOSINE; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; IN SITU NICK-END LABELING; INDOLEQUINONES; ISOQUINOLINES; MESENCEPHALON; MICE; POLY(ADP-RIBOSE) POLYMERASES; PROPIDIUM; SUBCELLULAR FRACTIONS; TIME FACTORS;

MURINAE;

EID: 84862208574     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07756.x     Document Type: Article

References (55)

1. Andersen J. K., (2004) Oxidative stress in neurodegeneration: cause or consequence? Nat. Med. 10 (Suppl.), S18-S25. (Pubitemid 38901863)
2. Banerjee R., Sreetama S., Saravanan K. S., Dey S. N., and, Mohanakumar K. P., (2007) Apoptotic mode of cell death in substantia nigra following intranigral infusion of the Parkinsonian neurotoxin, MPP(+) in Sprague-Dawley rats: cellular, molecular and ultrastructural evidences. Neurochem. Res. 32, 1238-1247. (Pubitemid 46817473)
3. Beal M. F., (1992) Mechanisms of excitotoxicity in neurologic diseases. Faseb J. 6, 3338-3344. (Pubitemid 23007098)
4. Bisaglia M., Mammi S., and, Bubacco L., (2007) Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with alpha-synuclein. J. Biol. Chem. 282, 15597-15605. (Pubitemid 47093273)
5. Borner C., and, Monney L., (1999) Apoptosis without caspases: an inefficient molecular guillotine? Cell Death Differ. 6, 497-507. (Pubitemid 29292105)
6. Branco D. M., Arduino D. M., Esteves A. R., Silva D. F., Cardoso S. M., and, Oliveira C. R., (2010) Cross-talk between mitochondria and proteasome in Parkinson's disease pathogenesis. Front. Aging Neurosci. 2, 17.
7. Bras M., Queenan B., and, Susin S. A., (2005) Programmed cell death via mitochondria: different modes of dying. Biochemistry (Mosc) 70, 231-239. (Pubitemid 40512332)
8. Burguillos M. A., Hajji N., Englund E., Persson A., Cenci A. M., Machado A., Cano J., Joseph B., and, Venero J. L., (2011) Apoptosis-inducing factor mediates dopaminergic cell death in response to LPS-induced inflammatory stimulus: evidence in Parkinson's disease patients. Neurobiol. Dis. 41, 177-188.
9. Cande C., Cohen I., Daugas E., Ravagnan L., Larochette N., Zamzami N., and, Kroemer G., (2002) Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria. Biochimie 84, 215-222.
10. Chen L., Ding Y., Cagniard B., Van Laar A. D., Mortimer A., Chi W., Hastings T. G., Kang U. J., and, Zhuang X., (2008) Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice. J. Neurosci. 28, 425-433.
11. Chu C. T., Zhu J. H., Cao G., Signore A., Wang S., and, Chen J., (2005) Apoptosis inducing factor mediates caspase-independent 1-methyl-4- phenylpyridinium toxicity in dopaminergic cells. J. Neurochem. 94, 1685-1695. (Pubitemid 41324649)
12. Cregan S. P., Dawson V. L., and, Slack R. S., (2004) Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene 23, 2785-2796. (Pubitemid 38638842)
13. Daugas E., Susin S. A., Zamzami N., et al. (2000) Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. Faseb J. 14, 729-739. (Pubitemid 30198571)
14. De Iuliis A., Arrigoni G., Andersson L., Zambenedetti P., Burlina A., James P., Arslan P., and, Vianello F., (2008) Oxidative metabolism of dopamine: a colour reaction from human midbrain analysed by mass spectrometry. Biochim. Biophys. Acta 1784, 1687-1693.
15. Dodson M. W., and, Guo M., (2007) Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease. Curr. Opin. Neurobiol. 17, 331-337. (Pubitemid 46880329)
16. Ebadi M., Srinivasan S. K., and, Baxi M. D., (1996) Oxidative stress and antioxidant therapy in Parkinson's disease. Prog. Neurobiol. 48, 1-19. (Pubitemid 26111215)
17. Foley P., and, Riederer P., (2000) Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson's disease. J. Neurol., 247 (Suppl 2), II82-II94.
18. Galluzzi L., and, Kroemer G., (2008) Necroptosis: a specialized pathway of programmed necrosis. Cell 135, 1161-1163.
19. Galzigna L., Zanatta L., and, Esposito N., (1999) Toxicity of dopamine and dopaminochrome on cultured cells. Neurotox. Res. 1, 149-152.
20. Golstein P., and, Kroemer G., (2007) Cell death by necrosis: towards a molecular definition. Trends Biochem. Sci. 32, 37-43. (Pubitemid 46043552)
21. Graham D. G., (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14, 633-643. (Pubitemid 8402469)
22. Hong S. J., Dawson T. M., and, Dawson V. L., (2004) Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol. Sci. 25, 259-264. (Pubitemid 38553828)
23. Jeon S. M., Cheon S. M., Bae H. R., Kim J. W., and, Kim S. U., (2010) Selective susceptibility of human dopaminergic neural stem cells to dopamine-induced apoptosis. Exp. Neurobiol. 19, 155-164.
24. Kaushal V., and, Schlichter L. C., (2008) Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J. Neurosci. 28, 2221-2230. (Pubitemid 351317617)
25. Keeney P. M., Xie J., Capaldi R. A., and, Bennett J. P. Jr., (2006) Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J. Neurosci. 26, 5256-5264. (Pubitemid 44315308)
26. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., and, Shimizu N., (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608. (Pubitemid 28207717)
27. Kostrzewa R. M., (2000) Review of apoptosis vs. necrosis of substantia nigra pars compacta in Parkinson's disease. Neurotox. Res. 2, 239-250.
28. Kostrzewa R. M., and, Segura-Aguilar J., (2003) Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review. Neurotox. Res. 5, 375-383.
29. Linsenbardt A. J., Wilken G. H., Westfall T. C., and, Macarthur H., (2009) Cytotoxicity of dopaminochrome in the mesencephalic cell line, MN9D, is dependent upon oxidative stress. Neurotoxicology 30, 1030-1035.
30. Liu H. Q., Zhu X. Z., and, Weng E. Q., (2005) Intracellular dopamine oxidation mediates rotenone-induced apoptosis in PC12 cells. Acta Pharmacol. Sin. 26, 17-26.
31. Mallajosyula J. K., Kaur D., Chinta S. J., Rajagopalan S., Rane A., Nicholls D. G., Di Monte D. A., Macarthur H., and, Andersen J. K., (2008) MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology. PLoS ONE 3, e1616.
32. Martin S. J., Reutelingsperger C. P., McGahon A. J., Rader J. A., van Schie R. C., LaFace D. M., and, Green D. R., (1995) Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182, 1545-1556.
33. Martin I., Dawson V. L., and, Dawson T. M., (2011) Recent advances in the genetics of Parkinson's disease. Annu. Rev. Genomics Hum. Genet. 12, 301-325.
34. Mills J. C., Stone N. L., Erhardt J., and, Pittman R. N., (1998) Apoptotic membrane blebbing is regulated by myosin light chain phosphorylation. J. Cell Biol. 140, 627-636. (Pubitemid 28134065)
35. Naoi M., Yi H., Maruyama W., Inaba K., Shamoto-Nagai M., Akao Y., Gerlach M., and, Riederer P., (2009) Glutathione redox status in mitochondria and cytoplasm differentially and sequentially activates apoptosis cascade in dopamine-melanin-treated SH-SY5Y cells. Neurosci. Lett. 465, 118-122.
36. Ochs S. D., Westfall T. C., and, Macarthur H., (2005) The separation and quantification of aminochromes using high-pressure liquid chromatography with electrochemical detection. J. Neurosci. Methods 142, 201-208. (Pubitemid 40215455)
37. Olanow C. W., (2007) The pathogenesis of cell death in Parkinson's disease - 2007. Mov. Disord. 22 (Suppl. 17), S335-342. (Pubitemid 350134186)
38. Raza H., and, John A., (2006) 4-Hydroxynonenal induces mitochondrial oxidative stress, apoptosis and expression of glutathione S-transferase A4-4 and cytochrome P450 2E1 in PC12 cells. Toxicol. Appl. Pharmacol. 216, 309-318. (Pubitemid 44466011)
39. Rimon G., Bazenet C. E., Philpott K. L., and, Rubin L. L., (1997) Increased surface phosphatidylserine is an early marker of neuronal apoptosis. J. Neurosci. Res. 48, 563-570. (Pubitemid 27276686)
40. Schapira A. H., and, Gegg M., (2011) Mitochondrial contribution to Parkinson's disease pathogenesis. Parkinsons Dis. 2011, 159160.
41. Schulz J. B., and, Gerhardt E., (2001) Apoptosis: its relevance to Parkinson's disease. Clin. Neurosci. Res. 1, 427-433. (Pubitemid 33665561)
42. Segura Aguilar J., and, Kostrzewa R. M., (2004) Neurotoxins and neurotoxic species implicated in neurodegeneration. Neurotox. Res. 6, 615-630.
43. Shadrina M. I., Slominsky P. A., and, Limborska S. A., (2010) Molecular mechanisms of pathogenesis of Parkinson's disease. Int. Rev. Cell Mol. Biol. 281, 229-266.
44. Shiratsuchi A., Mori T., and, Nakanishi Y., (2002) Independence of plasma membrane blebbing from other biochemical and biological characteristics of apoptotic cells. J. Biochem. 132, 381-386.
45. Sulzer D., (2007) Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease. Trends Neurosci. 30, 244-250. (Pubitemid 46667168)
46. Sulzer D., Bogulavsky J., Larsen K. E., et al. (2000) Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc. Natl Acad. Sci. USA 97, 11869-11874.
47. Susin S. A., Daugas E., Ravagnan L., et al. (2000) Two distinct pathways leading to nuclear apoptosis. J. Exp. Med. 192, 571-580.
48. Van Laar V. S., Mishizen A. J., Cascio M., and, Hastings T. G., (2009) Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells. Neurobiol. Dis. 34, 487-500.
49. Vermes I., Haanen C., Steffens-Nakken H., and, Reutelingsperger C., (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184, 39-51.
50. Wang N., Wang Y., Yu G., Yuan C., and, Ma J., (2011) Quinoprotein adducts accumulate in the substantia nigra of aged rats and correlate with dopamine-induced toxicity in SH-SY5Y cells. Neurochem. Res. 36, 2169-2175.
51. Whitton P. S., (2007) Inflammation as a causative factor in the aetiology of Parkinson's disease. Br. J. Pharmacol. 150, 963-976. (Pubitemid 46628616)
52. Yu S. W., Wang H., Poitras M. F., Coombs C., Bowers W. J., Federoff H. J., Poirier G. G., Dawson T. M., and, Dawson V. L., (2002) Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297, 259-263. (Pubitemid 34761289)
53. Yu S. W., Wang H., Dawson T. M., and, Dawson V. L., (2003) Poly(ADP-ribose) polymerase-1 and apoptosis inducing factor in neurotoxicity. Neurobiol. Dis. 14, 303-317. (Pubitemid 37543510)
54. Zecca L., Fariello R., Riederer P., Sulzer D., Gatti A., and, Tampellini D., (2002) The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease. FEBS Lett. 510, 216-220. (Pubitemid 34093828)
55. Zimprich A., Biskup S., Leitner P., et al. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601-607. (Pubitemid 39531225)